Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
30.9M
-
Shares change
-
+4.5M
-
Total reported value, excl. options
-
$761M
-
Value change
-
+$114M
-
Put/Call ratio
-
5.16
-
Number of buys
-
70
-
Number of sells
-
-52
-
Price
-
$24.65
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2017
155 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2017.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.9M shares
of 101M outstanding shares and own 30.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.05M shares), BlackRock Inc. (4.45M shares), FMR LLC (1.69M shares), STATE STREET CORP (1.51M shares), JANUS CAPITAL MANAGEMENT LLC (1.36M shares), JPMORGAN CHASE & CO (1.14M shares), Hillhouse Capital Management, Ltd. (1M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (975K shares), Omega Fund Management, LLC (812K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (811K shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.